Institutional Manager · CIK 0001512848
NEA Management Company, LLC
TIMONIUM, MD · File #028-14302
Latest AUM
$1.96B
Positions
27
Top-10 Concentration
86.5%
Filings
9
Portfolio Value Over Time
2024-03
2024-06
2024-09
2024-12
2025-03
2025-06
2025-09
2025-12
Biggest QoQ Changes
Ranked by conviction flow (share change × current price) so mark-to-market moves don't dominate. Price effect column shows how much of the $ change was just the stock moving.
| Action | Issuer | Ticker / CUSIP | Δ Shares | Flow ($) | Price Effect |
|---|---|---|---|---|---|
| EXITED | VERONA PHARMA PLC | 925050106 | -2,252,994 | -$240.4M | $0 |
| ADD | Celcuity Inc. | CELC | +1,391,300 | +$138.8M | +$107.9M |
| ADD | Zenas BioPharma, Inc. | ZBIO | +789,500 | +$28.7M | +$38.6M |
| EXITED | NEUEHEALTH INC | 10920V404 | -2,726,917 | -$18.2M | $0 |
| EXITED | OMADA HEALTH INC | 68170A108 | -364,115 | -$8.1M | $0 |
| ADD | X4 Pharmaceuticals, Inc. | XFOR | +1,000,000 | +$4.0M | +$1.3M |
| NEW | LeonaBio, Inc. | 04746L203 | +464,398 | +$3.5M | $0 |
| REDUCE | Arcellx, Inc. | ACLX | 0 | $0 | -$51.5M |
| REDUCE | Aurinia Pharmaceuticals, Inc. | AUPH | 0 | $0 | +$19.5M |
| REDUCE | Black Diamond Therapeutics, Inc. | BDTX | 0 | $0 | -$6.1M |
Sector Allocation
Filing History
- 13F HOLDINGS REPORTQ/E Dec 202527 pos · $1.96B
- 13F HOLDINGS REPORTQ/E Sep 202529 pos · $1.82B
- 13F HOLDINGS REPORTQ/E Jun 202532 pos · $1.33B
- 13F HOLDINGS REPORTQ/E Mar 202538 pos · $1.30B
- 13F HOLDINGS REPORTQ/E Dec 202442 pos · $1.77B
- 13F HOLDINGS REPORTQ/E Sep 202442 pos · $1.84B
- 13F HOLDINGS REPORTQ/E Jun 202441 pos · $1.33B
- 13F HOLDINGS REPORTQ/E Mar 202444 pos · $1.61B
- 13F HOLDINGS REPORTQ/E Dec 202346 pos · $1.29B
Top 20 Holdings — Dec 2025
| # | Issuer | Ticker | Shares | Value | % of Portfolio |
|---|---|---|---|---|---|
| 1 | Celcuity Inc. | CELC | 3,535,561 | $352.6M | 17.98% |
| 2 | Rhythm Pharmaceuticals, Inc. | RYTM | 2,909,956 | $311.5M | 15.88% |
| 3 | Arcellx, Inc. | ACLX | 3,045,262 | $198.6M | 10.12% |
| 4 | Trevi Therapeutics, Inc. | TRVI | 13,222,228 | $165.5M | 8.44% |
| 5 | Savara, Inc. | SVRA | 24,471,264 | $147.6M | 7.52% |
| 6 | Zenas BioPharma, Inc. | ZBIO | 3,523,219 | $127.9M | 6.52% |
| 7 | Monte Rosa Therapeutics, Inc. | GLUE | 7,692,298 | $120.6M | 6.15% |
| 8 | MBX Biosciences, Inc. | MBX | 3,614,486 | $114.0M | 5.81% |
| 9 | Coursera, Inc. | COUR | 12,867,769 | $94.7M | 4.83% |
| 10 | Aurinia Pharmaceuticals, Inc. | AUPH | 3,969,834 | $63.3M | 3.23% |
| 11 | Gossamer Bio, Inc. | GOSS | 18,093,034 | $56.1M | 2.86% |
| 12 | CRISPR Therapeutics AG | CRSP | 1,058,570 | $55.5M | 2.83% |
| 13 | ORIC Pharmaceuticals, Inc. | ORIC | 4,118,621 | $33.7M | 1.72% |
| 14 | Phathom Pharmaceauticals, Inc. | PHAT | 1,960,169 | $32.5M | 1.66% |
| 15 | CVRx, Inc. | CVRX | 2,026,083 | $14.4M | 0.73% |
| 16 | X4 Pharmaceuticals, Inc. | XFOR | 3,233,743 | $12.9M | 0.66% |
| 17 | Champions Oncology, Inc. | CSBR | 1,713,720 | $11.8M | 0.60% |
| 18 | Black Diamond Therapeutics, Inc. | BDTX | 4,448,757 | $10.8M | 0.55% |
| 19 | Korro Bio, Inc. | KRRO | 1,090,793 | $8.7M | 0.45% |
| 20 | Inventiva SA | IVEVF | 1,462,586 | $6.8M | 0.35% |